As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
At its annual Vaccines Day and Business Update on Wednesday, Moderna (MRNA) sought to show analysts and investors just how much its pipeline has advanced, four years after making history by ...
The continued evolution of SARS-CoV-2 into new variants, each as or more infectious than the last, underscores the ongoing need to update our vaccine defenses against the virus. While updated ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
A Victorian coroner is investigating whether a young woman's death from heart inflammation after receiving her third Covid-19 jab was caused by the Moderna vaccine. Moderna's lawyers appeared ...
Jamie Scott was left with a permanent brain injury after having a haemorrhage the day after the Covid vaccine Credit: Andrew Fox AstraZeneca has admitted for the first time in court documents that ...
WATCH: Nobel in medicine goes to scientists whose work on mRNA led to COVID vaccine Hungarian-American Katalin Karikó and American Drew Weissman were cited for contributing vaccine development ...
Older adults age 65 and over can now get another COVID vaccine this spring, after the Centers for Disease and Control and Prevention (CDC) formally recommended an extra shot for this age group. The ...
Moderna (MRNA) is advancing three of its vaccines into Phase Three trials as the pharmaceutical giant hopes to expand its product pipeline past its COVID-19 vaccine, sales of which fell by 43% ...
Ocugen Inc. shares OCGN, +5.74% climbed 9% early Friday after a federal appeals court on Thursday upheld a lower court’s ruling against shareholders who alleged the biotech company misled ...